"Precision Medicine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Clinical, therapeutic and diagnostic approaches to optimal disease management based on individual variations in a patient's genetic profile.
| Descriptor ID |
D057285
|
| MeSH Number(s) |
E02.574 H02.403.200.700
|
| Concept/Terms |
Precision Medicine- Precision Medicine
- Medicine, Precision
- Personalized Medicine
- Medicine, Personalized
- Individualized Medicine
- Medicine, Individualized
|
Below are MeSH descriptors whose meaning is more general than "Precision Medicine".
Below are MeSH descriptors whose meaning is more specific than "Precision Medicine".
This graph shows the total number of publications written about "Precision Medicine" by people in this website by year, and whether "Precision Medicine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 2 | 0 | 2 |
| 2010 | 2 | 1 | 3 |
| 2011 | 7 | 2 | 9 |
| 2012 | 2 | 4 | 6 |
| 2013 | 4 | 1 | 5 |
| 2014 | 3 | 4 | 7 |
| 2015 | 13 | 10 | 23 |
| 2016 | 18 | 13 | 31 |
| 2017 | 11 | 7 | 18 |
| 2018 | 9 | 18 | 27 |
| 2019 | 12 | 11 | 23 |
| 2020 | 8 | 13 | 21 |
| 2021 | 5 | 11 | 16 |
| 2022 | 8 | 13 | 21 |
| 2023 | 6 | 14 | 20 |
| 2024 | 13 | 8 | 21 |
| 2025 | 14 | 7 | 21 |
| 2026 | 7 | 9 | 16 |
To return to the timeline,
click here.
Below are the most recent publications written about "Precision Medicine" by people in Profiles.
-
A complete diploid human genome benchmark for personalized genomics. Cell. 2026 Aug 06; 189(16):4857-4875.e31.
-
Colocalization of eQTLs With Type 2 Diabetes and Glycemic Traits Using Whole-Genome Sequences in Diverse Populations From the NHLBI Trans-Omics in Precision Medicine (TOPMed) Program. Diabetes. 2026 Aug 01; 75(8):1477-1491.
-
Time to Personalize Surveillance for Cancer Therapy-Related Cardiac Dysfunction in HER2-Targeted Therapy: One Size Does Not Fit All. Curr Heart Fail Rep. 2026 Jul 22; 23(1).
-
Harmonizing standards and resources for the medical genome. Nature. 2026 Jul; 655(8121):47-58.
-
Personalized targeting of BCL2 family proteins overcomes acquired resistance to BRAF-MEK inhibitors in preclinical melanoma. Nat Commun. 2026 Jun 26; 17(1).
-
Practice parameter for inborn errors of immunity: What is new in the 2025 update. J Allergy Clin Immunol. 2026 Aug; 158(2):368-373.
-
Rationale and study design for the first precision medicine randomized placebo-controlled trial in the 16p11.2 deletion syndrome. Expert Rev Neurother. 2026 Jun; 26(6):597-607.
-
Plasma metabolomic profiles associated with cardiovascular disease in type 2 diabetes from the Trans-Omics for Precision Medicine (TOPMed) program. Atherosclerosis. 2026 Jun; 417:120758.
-
Utility of donor-derived cell-free DNA testing after lung transplantation in the precision medicine era. J Heart Lung Transplant. 2026 Aug; 45(8):1251-1269.
-
Mondo: integrating disease terminology across communities. Genetics. 2026 04 04; 232(4).